Can Bicara Therapeutics cover its short-term obligations?

Its current ratio is 13.85 — current assets exceed current liabilities.

Where does Bicara Therapeutics's balance sheet data come from?

Every line is extracted from Bicara Therapeutics's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.

Bicara Therapeutics BCAX Balance Sheet Statement

Income Statement Balance Sheet Cash Flow Ratios Segments

Quarterly Annual TTM

YoY QoQ

Simplified Detailed

	TTM Q1 '26	TTM Q4 '25	TTM Q3 '25	TTM Q2 '25	TTM Q1 '25
Cash and cash equivalents	$323.46M+235%	$96.69M-43.7%	$171.67M-60.7%	$436.61M-5.5%	$462.07M-5.6%
Short-term investments	——	——	——	——	——
Total current assets	$544.92M+29.1%	$422.05M+41.9%	$297.37M-33.1%	$444.39M—	——
Property and equipment, net	$346K+4.8%	$330K+144%	$135K+15.4%	$117K—	——
Total assets	$553.6M+28.4%	$430.99M+1.5%	$424.69M-6.4%	$453.59M—	——
Total current liabilities	$39.34M+35.9%	$28.95M+37.7%	$21.03M+22.1%	$17.23M—	——
Total liabilities	$39.64M+34.2%	$29.54M+34.8%	$21.91M+19.1%	$18.39M—	——
Common stock	500M0.0%	500M0.0%	500M0.0%	500M—	——
Retained earnings	-$415.18M-15.7%	-$358.97M-11.6%	-$321.58M-12.7%	-$285.25M—	——
Total stockholders' equity	$513.96M+28.0%	$401.45M-0.3%	$402.78M-7.4%	$435.2M-5.2%	$458.96M-6.7%
Total liabilities and stockholders' equity	$553.6M+28.4%	$430.99M+1.5%	$424.69M-6.4%	$453.59M—	——

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

Can Bicara Therapeutics cover its short-term obligations?: Its current ratio is 13.85 — current assets exceed current liabilities.
Where does Bicara Therapeutics's balance sheet data come from?: Every line is extracted from Bicara Therapeutics's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.